|
|
Top Story |
 |
Value Assessment of Drugs Here to Stay |
Despite differences and deficiencies in the frameworks for assessing the value of prescription drugs that have emerged in recent months, these initiatives are expected to have a major impact on drug utilization and reimbursement, and even on decisions related to developing new therapies
... /Read more/ |
|
|
Advertisement |
Provider organizations are going local to increase their treatment influence and market share. Our new research and analysis reveals that the U.S. now has 104 self-contained local healthcare markets. Our research also revealed that pharma isn’t ready for local commercial engagement. Read this article to learn more about how pharma can enable its commercial model for the new healthcare ecosystem
|
|
Advertisement |
Podcast: Assuring Trust in the Digital Space
Pharm Exec talks to Mollie Shields-Uehling, a leading advocate for high-assurance identity trust for cyber-transactions in the biopharmaceutical industry. Listen to the podcast for a timely, 15-minute discussion covering topics like cyber/technical security; eHealth regulatory compliance; work flow automation, the benefits of eSignature programs, and collaboration around key aspects of drug development like the administration of clinical trials and research partnering
Click here to listen |
|
|
Advertisement |
Read this Front & Center article to see how your Hub can be a Secret Weapon to improve Outcomes
Learn more |
|
|
Special Feature |
 |
Pharm Exec's Emerging Pharma Leaders 2016 |
Pharm Exec's 9th annual list of rising industry leaders illustrates how the deployment of essential human capital has changed in line with a business model that is no longer static and predictable–or complacent
... /Read more/ |
|
Advertisement |
Achieving Success in the Biosimilar Market
Live Webinar: Wednesday, October 19 at 2 PM EDT
Register now |
|
|
|
ADVERTISEMENT
|
Advertisement |
Supporting internal and external decision-making through effective MSL activities
Live Webinar: Tuesday 18th October, 11:00am EDT
Register now |
|
|
Advertisement |
Technology can't replace people– why Patient Support Programs need a personal approach
On Demand
Learn more |
|
|
Industry update |
//Astellas (Northbrook, IL) announced the appointment of Steven E. Benner, M.D., as Senior Vice President and Therapeutic Area Head for Oncology, and the promotion of Anne Keating, Pharm. D., to Vice President of Clinical Science for Oncology.//The Indiana Biosciences Research Institute (Indianapolis, IN) announced the appointment of Prof. Rainer Fischer, Ph.D., as its Chief Scientific and Innovation Officer. //BeiGene, Ltd. (Waltham, MA) appointed Ross Pettit as Senior Vice President, Global Development Operations.//INC Research Holdings, Inc. (Raleigh, NC) announced the promotion of Michael Gibertini, PhD to Chief Operating Officer (COO) succeeding Alistair Macdonald, and the promotion of Tara Fitzgerald, Executive Vice President, Biometrics, to President, Clinical Development Services.// |
Advertisement |
Optimizing real-world evidence programs to generate value Tailored approaches for emerging biopharma
On Demand
Learn more |
|
|
|
|